The report concluded that it is reasonable to prescribe

the 0.15 mg dose for children between 10 and 25 kg (22 to 55 lbs) and 
the 0.3 mg dose for those over 25 kg (55 lbs). 

Dosing might be individualized to select the higher of the two fixed doses at lower weights for children with severe past reactions.